 |
 |
 |
 |
 |
 |
 |
 |
-
BROWSE TOPICS IN CLINICAL MANAGEMENT:
Antiretroviral Therapy- Complications of HIV/HAART
- Research & Development
- Clinical Trials
- Quality of Life & Patient Care
Antiretroviral Therapy
Hepatitis C Medications
Approved Medications
- ddI + Ribavirin May Cause Mitochondrial Toxicity (September 1, 2005)
In Journal of Acquired Immune Deficiency Syndromes - Focus on Hepatitis: Final APRICOT, ACTG A5071 Results (September 2004)
Data indicate that sustained virologic response can be achieved with peginterferon-alfa and ribavirin in many HIV/hepatitis C-coinfected patients.
To read PDF, click here
In IAPAC Monthly, from International Association of Physicians in AIDS Care - The Management of Adverse Effects with PEG-Interferon/Ribavirin Combination Therapy is a Significant Challenge (March 2003)
To read PDF, click here
From HCV Advocate - FDA Approves Pegasys for Hepatitis C (October 17, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Study: Hepatitis Shots Show Promise (September 26, 2002)
In a recent study, peginterferon alfa-2a plus ribavirin beats the standard hepatitis C treatment.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Important Drug Warning: Intron A (PDF) (December 2001)
From U.S. Food and Drug Administration - Novel Treatments for HCV (October 21, 2001)
In 66th Annual Scientific Meeting of the American College of Gastroenterology, from The Body PRO - Hepatitis C: Progress Beyond Interferon (October 19, 2001)
In 66th Annual Scientific Meeting of the American College of Gastroenterology, from The Body PRO - FDA Approves Peg-Interferon and Ribavirin Treatment Combination (September 21, 2001)
To read PDF, click here
In STEP Ezine, from Seattle Treatment Education Project - Important Drug Warning: Roferon-A (PDF) (September 2001)
From U.S. Food and Drug Administration - FDA Approves Stand-Alone Package of Rebetol (Ribavirin) for Combination Therapy With Intron A for the Treatment of Chronic Hepatitis C Infection (July 26, 2001)
See also Rebetol (Ribavirin) Product Information (2001).
From U.S. Food and Drug Administration - Revised Package Insert: Roferon-A (Interferon Alfa-2a, Recombinant) (PDF) (March 20, 2001)
From U.S. Food and Drug Administration - Peg-Interferon-Alfa Approved for Hepatitis C (March 2001)
In What's New, from Project Inform - Revised Package Insert: Intron A (Interferon Alfa-2b, Recombinant for Injection) (PDF) (February 2001)
From U.S. Food and Drug Administration
New or Experimental Medications
- Hepatitis C: New Treatments in the Pipeline (April 2008)
To read PDF, click here
From Treatment Action Group - Is a New Generation of HCV Treatment Near? (November 2, 2007)
In The New York Times - What’s in the Hep C Pipeline? (Fall 2007)
To read PDF, click here
In ACRIA Update, from AIDS Community Research Initiative of America - Studying New Drugs for HCV (September 2007)
Excerpts from the FDA hearings.
To read PDF, click here
In TAGline, from Treatment Action Group - The Sitges Statement on HCV Drug Development (September 2007)
To read PDF, click here
In TAGline, from Treatment Action Group - Research Into New Drugs to Treat HCV (August 2007)
To read PDF, click here
In Guide to Hepatitis C for People Living With HIV, from Treatment Action Group - Hepatitis C at CROI: Growing Chasm Between Bench and Bedside (April 2006)
A brief review of research on experimental treatments presented at the 13th Conference on Retroviruses and Opportunistic Infections.
To read PDF, click here
In TAGline, from Treatment Action Group - The Hepatitis C Treatment Pipeline (Spring 2006)
To read PDF, click here
In ACRIA Update, from AIDS Community Research Initiative of America - FDA Approves Hepatitis C Treatment Ribasphere (December 9, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Vertex's Hepatitis C Drug VX-950 Gets FDA Fast Track (December 9, 2005)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - The Hepatitis C Virus Treatment Pipeline (September 29, 2005)
To read PDF, click here
In TAGline, from Treatment Action Group - Protease Inhibitors for Hepatitis C Treatment: Glimpses of Hope on a Distant Horizon (August 2004)
To read PDF, click here
In IAPAC Monthly, from International Association of Physicians in AIDS Care - Proliferation of Polymerase Inhibitors and Other Tales From the HCV Crypt (February 2004)
A look at the various drugs in the hepatitis C treatment pipeline.
In TAGline, from Treatment Action Group - Hepatitis C Treatment May Halve Injections (November 6, 2002)
Albuferon-alpha may be easier treatment.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Novel Treatments for HCV (October 21, 2001)
In 66th Annual Scientific Meeting of the American College of Gastroenterology, from The Body PRO
Drug Pricing
- T-20, Pegasys Prices: How High the Sky? (November 2002)
In GMHC Treatment Issues, from Gay Men's Health Crisis
  |
  |